1999); clopidogrel bisulfate (Plavix), 75 mg daily (Albers et al.); or extended-release dipryridamole 400 mg with Aspirin 50 mg (Aggrenox), daily (Albers & Easton; Albers et al; Sarasin ...

The active ingredient in Plavix is clopidogrel bisulphate, a single dextro-rotatory enantiomer of a thienopyridine compound, which has patent protection until 2011. However, in 2001, generics ...

Patents covering Sanofi-Synthelabo/BMS's oral antiplatelet chiral drug Plavix (clopidogrel bisulfate) are under legal fire in the United States from generics companies, Apotex and Dr Reddy's ...